Table 1. Hydration Evidence.
First Author, Year Study Design | Subjects | Findings | GRADE quality level |
---|---|---|---|
Droller, 1982 Prospective, descriptive | 198 adult patients with oncology or aplastic anemia diagnosis | Significant HC prevalence difference between no hydration and IV fluids at 4-5 liters per day during CTX infusion (p< 0.01) | High |
Haselberger, 1995 Literature review | Published evidence: high dose CTX in SCT | Hydration/adequate urine flow should be mandatory with high dose CTX | Moderate |
Ballen, 1999 Prospective, descriptive | 100 SCT adult patients | Hydration with IV fluids at 250 ml/hr for 4 hours before through 24 hours after CTX effective in reducing HC | Moderate |
Takamoto, 2004 Case study | 19 pediatric patients with solid tumor or hematological disease | Acrolein concentrations increased as urine volume decreased; peak times were 1-12 hours after CTX | Low |
Abbreviations: SCT = stem cell transplant; IV = intravenous; CTX = Cytoxan; HC = hemorrhagic cystitis